Cambridge Cognition Holdings PLC Directorate Change
18 10월 2024 - 3:00PM
RNS Regulatory News
RNS Number : 6785I
Cambridge Cognition Holdings PLC
18 October 2024
18 October 2024
Cambridge Cognition Holdings
plc
("Cambridge Cognition", the "Company" or the
"Group")
Directorate
change
Cambridge Cognition Holdings Plc
(AIM: COG), which develops and markets digital solutions to assess
brain health, announces that, further to the announcement made on
12 September 2024 in which it stated that Dr Matthew Stork had
stepped down as Chief Executive Officer, the Company has now
received the formal resignation of Dr Stork as a Director of the
Company and all subsidiary entities of which he was a
Director.
Enquiries:
|
Cambridge Cognition Holdings
plc
Dr Steven Powell,
Chairman
|
c/o Hudson
Sandler
|
|
Panmure Liberum Limited (NOMAD and
Joint Broker)
Freddy Crossley / Will Goode / Mark
Rogers
Rupert Dearden
|
Tel: 020 7886
2968
(Corporate
Finance)
(Corporate
Broking)
|
|
Dowgate Capital Limited (Joint
Broker)
David Poutney / James
Serjeant
|
Tel: 020 3903
7715
|
|
Hudson Sandler (Financial PR and
IR)
Dan de Belder / Hattie
Dreyfus / Harry Griffiths
|
Tel: 020 7796
4133
cog@hudsonsandler.com
|
|
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology
company developing digital health products to better understand,
detect and treat conditions affecting brain health. The Company's
software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients
early and improve global efficiency in pharmaceutical and
healthcare industries.
For further information
visit: https://cambridgecognition.com/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
BOAGZMMGRNMGDZM
Cambridge Cognition (LSE:COG)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Cambridge Cognition (LSE:COG)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
